Comparison of the efficacy of methadone and tramadol in opioid-assisted detoxification

Iranian Journal of Medical Sciences

Volumn 32, Issue 1, 2007, Pages 28-31

  Salehi, M ^a   Amanatkar, M ^a   Barekatain, Majid ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Methadone; Opioids; Tramadol

Indexed keywords

CLONIDINE; METHADONE; OXAZEPAM; TRAMADOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG MECHANISM; HUMAN; MALE; OPIATE ADDICTION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SWEATING; WITHDRAWAL SYNDROME;

EID: 34548845324     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hafezi M, Asaadi SM, Razzaghi OM, Mokri A. High Doses of Buprenorphin in One day Opium Detoxification. Andisheh Va Raftar 2005; 10: 196-202.(Persian)
2. Farrell M. Opiate withdrawal. Addiction 1994; 89: 1471-5.
3. Oldham NS, Wright NM, Adams CE, et al. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) project: an open-label pragmatic randomized control trial comparing the efficacy of differing therapeutic agents for primary care detoxification from either street heroin or methadone. BMC Fam Pract 2004; 5: 9.
4. Jaffe JH, Strain EC. Opioid-Related Disorders. In: Sadock BJ, Sadock VA, editors. Kaplan and sadock's. Comprehensive Textbook of Psychiatry. Philadelphia (PA): Lippincott Williams & Wilkins; 2004. p. 1265-90.
5. Layson-Wolf C, Goode JV, Small RE. Clinical use of methadone. J Pain Palliat Care Pharmacother 2002; 16: 29-59.
6. Dayer P, Desmeules J, Collart L. Pharmacology of tramadol. Drug 1997; 53: 18-24.
7. Lee CR, McTavish D, Sorkin EM. Tramadol: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs 1993; 46: 313-40.
8. Hopwood SE, Owesson CA, Callado LF, et al. Effects of chronic tramadol on pre-and post-synaptic measures of monoamine function. J Psychopharmacol 2001; 15: 147-53.
9. Rojas-Corrales MO, Berrocoso E, Mico JA. Role of 5-HT1A and 5-HT1B receptors in the antinociceptive effect of tramadol. Eur J Pharmacol 2005; 511: 21-6.
10. Gossop M. The Development of Short Opiate Withdrawal Scale (SOWS). Addict Behav 1990; 15: 487-90.
11. Gowing L, Ali R, White J. Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database Syst Rev 2002; 2: CD002021.
12. Bell JR, Young MR, Masterman SC, et al. A pilot study of naltrexone-accelerated detoxification in opioid dependence. Med J Aust 1999; 171: 26-30.
13. Handelsman L, Cochrane KJ, Aronson MJ, Ness RA, Rubinstein KJ, Kanof PB. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987; 13: 293-308.
14. Tamaskar R, Parran TV Jr, Heggi A, et al. Tramadol versus bupironorphine for the treatment of opiate withdrawal a retrospective cohort study. J Addict Dis 2003; 22: 5-12.